Term Gallery logo

Significados de adenocarcinoma of the esophagus en inglés

Esophageal carcinoma that derives from epithelial cells of glandular origin.

      Sinónimos
      Examples for "oesophageal adenocarcinoma nos"
      Examples for "oesophageal adenocarcinoma nos"
      1
      During the last 30 years, the incidence of oesophageal adenocarcinoma has increased rapidly.
      Pubmed
      2
      Methods: Consecutive patients with oesophageal adenocarcinoma who underwent PET-CT before neoadjuvant chemotherapy and resection were included.
      Pubmed
      3
      Patients with Barrett's oesophagus have an increased risk of developing oesophageal adenocarcinoma and should be kept under surveillance.
      Pubmed
      4
      There are few epidemiological data on the dietary risk factors of Barrett's oesophagus, a precursor of oesophageal adenocarcinoma.
      Pubmed
      5
      The incidence of oesophageal adenocarcinoma (EADC) is rapidly increasing in Western countries and obesity is thought to be a major risk factor.
      Pubmed
      1
      Barrett's esophagus is an important step in the pathway to esophageal adenocarcinoma.
      Pubmed
      2
      Context: The incidence of esophageal adenocarcinoma is rising and has surpassed squamous cell carcinoma.
      Pubmed
      3
      Future studies of trastuzumab in esophageal adenocarcinoma are indicated.
      Pubmed
      4
      Barrett's esophagus (BE) is the principal risk factor for esophageal adenocarcinoma.
      Pubmed
      5
      Barrett's esophagus is the precursor lesion for esophageal adenocarcinoma.
      Pubmed
      Uso de adenocarcinoma of the esophagus en inglés
      1
      Incidence rates for adenocarcinoma of the esophagus and gastric cardia have been rising rapidly.
      Pubmed
      2
      Methods and materials: Patients with adenocarcinoma of the esophagus without distant organ metastases were eligible.
      Pubmed
      3
      Incidence increased for several cancers, including pancreas, kidney, and adenocarcinoma of the esophagus, which are associated with excess weight.
      Pubmed
      4
      Patients and methods: Sixty-one patients with advanced, surgically unresectable, or metastatic squamous cell or adenocarcinoma of the esophagus were treated.
      Pubmed
      5
      A retrospective analysis should compare the two operative approaches, transhiatal or transthoracic resection in patients suffering from adenocarcinoma of the esophagus.
      Pubmed
      6
      Introduction: Even after potentially curative esophagectomy, the majority of patients with adenocarcinoma of the esophagus or gastroesophageal junction die due to cancer recurrence.
      Pubmed
      7
      Conclusions: There were significant differences in the gene profile between patients with adenocarcinoma of the esophagus responding to neoadjuvant chemotherapy compared with nonresponding patients.
      Pubmed
      8
      In summary, tumor uPA content as determined by ELISA appears to be a powerful, independent prognostic factor for survival in adenocarcinoma of the esophagus.
      Pubmed
      9
      Results: Compared to nonneoplastic epithelium, there was a significant increase in YAP cytoplasmic and nuclear localization in high-grade dysplastic epithelium and adenocarcinoma of the esophagus.
      Pubmed
      10
      Results: The median follow-up time for 518 patients was 29.3 months (range 1-149.2); all patients had adenocarcinoma of the esophagus.
      Pubmed
      11
      Adenocarcinoma of the esophagus and gastroesophageal junction (GEJ) has shown a remarkable increase during recent decades.
      Pubmed
      12
      Adenocarcinoma of the esophagus continues to increase in incidence and has become a significant health problem in Western countries.
      Pubmed